MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The shared risk of apolipoprotein E ɛ4-allele on hippocampal volume across the spectrum of Alzheimer’s disease and dementia with Lewy bodies: Evidence from the Sunnybrook Dementia Study

    U. Saeed, S. Mirza, B. MacIntosh, N. Herrmann, J. Keith, J. Ramirez, S. Nestor, J. Knight, W. Swardfager, E. Rogaeva, E. Black, M. Masellis (Toronto, ON, Canada)

    Objective: To identify the association of apolipoprotein E ɛ4-allele (APOE-ε4) with hippocampal volumes across the spectrum of Alzheimer’s disease (AD) and dementia with Lewy bodies…
  • 2018 International Congress

    Neuromelanin Imaging and Midbrain Volumetry in Progressive Supranuclear Palsy and Parkinson’s Disease

    D. Taniguchi, T. Hatano, K. Kamagata, A. Okuzumi, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

    Objective: Using neuromelanin-sensitive magnetic resonance imaging (NM-MRI) and midbrain volumetry, we analyzed differences and relationships between nigral degeneration and midbrain atrophy in PSP and PD…
  • 2018 International Congress

    Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson’s disease

    T. Barber, L. Griffanti, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To determine whether neuromelanin-MRI signal changes in the substantia nigra and locus coeruleus in patients with REM sleep behaviour disorder (RBD) are predictive of…
  • 2018 International Congress

    Patterns of dopamine transporter imaging in subtypes of Multiple System Atrophy

    F.T. Liu, L.L. Bu, Y.J. Yang, P. Wu, C.T. Zuo, J. Wang (Shanghai, China)

    Objective: To investigate the differences in the pattern of striatal (caudate and putamen) dopamine transporter(DAT) loss in a multiple system atrophy (MSA) cohort, based on…
  • 2018 International Congress

    Insular atrophy as a marker of depression in Multiple System Atrophy: A voxel-based morphometry study

    N. del Campo, N. Wolpe, O. Phillips, C. Arbus, F. Ory-Magne, M. Galitzky, C. Thalamas, C. Brefel-Courbon, A. Pavy-LeTraon, P. Péran, O. Rascol (Toulouse, France)

    Objective: The aim of this study was to determine the structural correlates of depressive symptoms in MSA patients. Background: Depression is highly prevalent among patients…
  • 2018 International Congress

    Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in healthy subjects (HS) and dementia with lewy body (DLB) patients (with visual hallucination) (VH) on…
  • 2018 International Congress

    Diencephalic mesencephalic junction abnormalities in adult-onset movement disorders

    A.M. Crespo Cuevas, V. Puente, S. Medrano, L. Planellas, D. Vilas (Barcelona, Spain)

    Objective: To describe two cases of adult-onset movement disorders with diencephalic-mesencephalic junction dysplasia(DMJD). Background: DMJD is a rare malformation characterized by a poorly defined junction…
  • 2018 International Congress

    Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

    P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)

    Objective: Using multimodal MRI, the aim of the study was to evaluate brain changes due to disease progression in multiple system atrophy (MSA) patients. Background:…
  • 2018 International Congress

    Safinamide inhibition of in vivo glutamate release in a rat model of Parkinson’s Disease

    G. Padoani, S. Novello, C. Pisanò, C. Caccia, E. Melloni, S. Vailati, C. Keywood, M. Morari (Bresso (Milan), Italy)

    Objective: To evaluate whether safinamide inhibits in vivo glutamate (Glu) release in a rodent model of Parkinson’s disease (PD), i.e. the 6-hydroxydopamine (6-OHDA) hemilesioned rat.…
  • 2018 International Congress

    Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

    D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)

    Objective: This study was designed with the objective to find out the possible synergistic effect of Curcumin (Cur) and Methanolic extract of Ginkgo biloba (EGB)…
  • « Previous Page
  • 1
  • …
  • 1211
  • 1212
  • 1213
  • 1214
  • 1215
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley